These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: An additional LDL-lowering effect of amlodipine; not only an antihypertensive?
    Author: Arslan Z, Ay SA, Karaman M, Cakar M, Celik T, Balta S, Akhan M, Sarlak H, Arslan E, Demirbas S, Demirkol S, Bulucu F, Saglam K.
    Journal: Clin Exp Hypertens; 2013; 35(6):449-53. PubMed ID: 23198737.
    Abstract:
    Hypertension is a modifiable risk factor for cardiovascular diseases and is associated with several metabolic disorders like dyslipidemia. Higher levels of triglyceride and low-density lipoprotein (LDL) are quite strong factors for the development of cardiovascular diseases. In this study, we investigated the effects of valsartan and amlodipine on the lipid profile in patients with newly diagnosed essential hypertension. We observed a beneficial effect of amlodipine on the lipid profile with a significant reduction of LDL compared to valsartan. In the treatment of hypertension, prior knowledge of the plasma cholesterol levels can be important in antihypertensive drug choice.
    [Abstract] [Full Text] [Related] [New Search]